What is Cnmri?
Historically recognized as a cornerstone of the Dover and Milford medical communities for over four decades, Cnmri specialized in neurology, sleep medicine, and advanced MRI diagnostics. Following the cessation of its legacy operations in September 2025, the organization underwent a strategic pivot. The emergence of CNMRI 2.0, led by Dr. Dave, represents a refined focus on neurology and neuroimaging, ensuring the continuity of critical diagnostic services. By maintaining rigorous standards for medical record retention and clinical excellence, the entity preserves its reputation as a vital provider in the Delaware healthcare landscape, bridging the gap between traditional practice management and modern, independent neuro-specialized care.
How much funding has Cnmri raised?
Cnmri has raised a total of $1.7M across 2 funding rounds:
Debt
$1M
Debt
$681K
Debt (2020): $1M with participation from PPP
Debt (2021): $681K led by PPP
Key Investors in Cnmri
PPP
Public-Private Partnership
What's next for Cnmri?
Looking ahead, the strategic focus for the successor entity, CNMRI 2.0, centers on scaling its independent neurology and neuroimaging capabilities. With the foundation provided by previous debt financing, the organization is positioned to optimize its diagnostic workflows and expand its patient reach within the region. The transition period post-closure serves as a critical phase for operational restructuring, allowing the practice to leverage its deep-rooted clinical expertise while adapting to the evolving demands of the neuro-diagnostic market. Future growth will likely be defined by the integration of advanced imaging technologies and the strengthening of referral networks, ensuring that the practice remains a primary destination for neurological care in the Delaware corridor.
See full Cnmri company page
